| License: Creative Commons Attribution 4.0 PDF - Published Version (214kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-593604
- DOI to cite this document:
- 10.5283/epub.59360
Abstract
Recently, the German Federal Institute for Medicines and Medical Products restricted the use of fosfomycin in transrectal biopsy of the prostate (TRBP). Accordingly, the need for other antibiotic agents for prophylaxis in TRBP is urgent since antibiotic prophylaxis is mandatory in accordance with these guidelines. After the restriction of the use of ciprofloxacin, and before the use of fosfomycin ...

Owner only: item control page

Download Statistics